Product Description
Chemical Name: Afatinibdimaleate
Synonyms :Afatinib (diMaleate)
| Gilotrif
Cas No : 850140-73-7
Purity : 98%
MolecularFormula : C24H25ClFN5O3.2C4H4O4
Molecular Weight: 718.1
Appearance:SolidPremium Quality and Regulatory ComplianceAfatinib dimaleate is supplied as a highly pure, crystalline powder with a minimum purity of 99%. It is produced to meet stringent international pharmaceutical standards and is supported by detailed batch certification, COA, and MSDS documentation. Regular audits ensure compliance with GMP manufacturing practices, making it suitable for regulated medical or pharmaceutical applications.
Safe Handling and Stable StorageThis anti-cancer agent must be handled using personal protective equipment and according to established safety protocols. For optimal stability, store the material between 28C in a dry, well-ventilated location, ensuring containers are tightly sealed and protected from light and moisture. Under these conditions, Afatinib dimaleate maintains stability for up to two years.
Versatile Applications in OncologyAfatinib dimaleate serves as both a pharmaceutical intermediate and an active ingredient in anti-cancer medications, with its primary usage being in the treatment of non-small cell lung cancer. Its chemical properties, such as hydrogen bond acceptance/donation, contribute to its efficacy and research value, making it a critical asset for pharmaceutical suppliers and researchers in India and worldwide.
FAQs of Afatinib dimaleate:
Q: How should Afatinib dimaleate be stored to ensure maximum stability?
A: Afatinib dimaleate should be stored at 28C in a tightly closed container, away from light and moisture, in a well-ventilated, dry place to maintain its stability for up to two years.
Q: What are the benefits of using Afatinib dimaleate in pharmaceutical applications?
A: Afatinib dimaleate offers high purity (99%), low total impurities (0.5%), and stable pharmaceutical-grade quality. Its proven efficacy as an anti-cancer drug ingredient, especially for non-small cell lung cancer, makes it indispensable in therapeutic and research use.
Q: When is Afatinib dimaleate typically used in clinical or research settings?
A: Afatinib dimaleate is primarily used as an active ingredient in the treatment of non-small cell lung cancer, as well as in pharmaceutical research and drug development for targeted cancer therapies.
Q: Where can I obtain batch certification and safety documentation for Afatinib dimaleate?
A: Batch-specific COA (Certificate of Analysis) and MSDS (Material Safety Data Sheet) are provided by the supplier and are available upon request with each order, ensuring full transparency and regulatory compliance.
Q: What precautions should be taken when handling Afatinib dimaleate?
A: Handle Afatinib dimaleate using personal protective equipment and follow GMP protocols. Avoid direct contact, ingestion, or inhalation, and ensure proper ventilation during handling to uphold laboratory safety standards.
Q: How is Afatinib dimaleate typically packaged for shipment?
A: The compound is packaged in high-density polyethylene (HDPE) bottles or double-layered polyethylene (PE) bags, with options for customized packaging based on client requirements to ensure safe and secure delivery.
Q: What is the process for ordering Afatinib dimaleate from suppliers in India?
A: To order, contact a certified supplier or trader providing Afatinib dimaleate (CAS No. 928791-11-5) in India. Ensure that pharmaceutical grade, batch certification, regulatory compliance, and shipping requirements are specified during procurement.